Filing Flows › Novartis AG (NVS) › Q3 2026 › vs Q3 2025
Novartis AG (NVS) Q3 2026 vs Q3 2025 (year over year)
Novartis AG's revenue rose $613M (+4%) from $13.9B in Q3 2025 to $14.5B in Q3 2026. Operating margin 12.7% against 32.4% (-19.7 pts).
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 12.7% | 32.4% | -19.7 pts |
| Net margin | 8.2% | 28.3% | -20.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $14.5B | $13.9B | $613M | +4% |
| Operating profit | $1.8B | $4.5B | −$2.7B | -59% |
| Costs & expenses | $12.7B | $9.4B | $3.3B | +35% |
| Pre-tax earnings | $1.2B | $3.9B | −$2.7B | -70% |
| Other expense, net | $647M | $571M | $76.0M | +13% |
| Net earnings | $1.2B | $3.9B | −$2.7B | -70% |
| Working capital & other | $4.3B | $2.6B | $1.7B | +63% |
| Operating cash flow | $5.5B | $6.6B | −$1.1B | -16% |
Questions
How much did Novartis AG's revenue grow year over year in Q3 2026?
Novartis AG's revenue rose $613M (+4%) from $13.9B in Q3 2025 to $14.5B in Q3 2026. Operating margin 12.7% against 32.4% (-19.7 pts).